U of M study: Hydroxychloroquine a poor defense against Covid-19

Anti-malaria drug hydroxychloroquine, which has become a hotly debated potential countermeasure to the coronavirus that causes Covid-19, does little to protect against the disease, University of Minnesota researchers have found.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.